MedTrace Logo

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

NCT05697861 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2025-08-26

No results posted yet for this study

Summary

This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Conditions

  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy
  • Wild-Type Transthyretin Cardiac Amyloidosis

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2038-03-31
Completion
2038-03-31

Countries

  • France
  • New Zealand
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05697861 on ClinicalTrials.gov